Who we are

The current IVG membership is:

AbbVie

AbbVie has been creating innovative products and services for patients for over 70 years and continue to push the boundaries of what is possible in eye care. They have a global reputation for innovation in ocular surface disease, glaucoma, retinal disease and presbyopia.

For further information on the company and its people, portfolio, and commitments, please visit www.abbvie.co.uk.

Apellis

We have grown from just a few scientists into a global biopharmaceutical company and we have intentionally fostered an entrepreneurial spirit across our organization. Apellis is formed by people who care, are fearless in the face of a challenge, love the work they do, and continually pursue the highest level of scientific integrity. Each of these values guide every decision we make as we strive toward our vision of being known for our compassion and revolutionary science.

We are fearless in the fight against vision loss and committed to moving the field forward.

For further information on the company and its people, portfolio, and commitments, please visit www.apellis.eu.

Bayer

Bayer is a life science company with a more than 150-year history. They focus on researching, developing, and marketing specialty-focused innovative medicines that provide significant clinical benefit and value. In ophthalmology, Bayer is helping reduce the number of people impacted globally by visual impairment through innovative products and research.

For further information on the company and its people, portfolio, and commitments, please visit www.bayer.co.uk/en/.

Glaukos

Founded in 1998, Glaukos is an ophthalmic medical technology and pharmaceutical company focused on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal disease. Since its launch, Glaukos has remained committed to pushing the limits of science and technology to improve outcomes for patients suffering from sight-threatening chronic eye diseases.

For further information on the company and its people, portfolio, and commitments, please visit: www.glaukos.com/en-uk

Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at www.jnj.co.uk.

Santen

Santen Pharmaceutical is one of the world’s leading specialist ophthalmic pharmaceutical companies, founded in Japan over a century ago and now serving patients all over the world. They’ve been active in the European market since 1994. They’re passionate about improving eye health and vision for patients and making beneficial treatments accessible to patients and healthcare systems. 

For further information on the company and its people, portfolio, and commitments, please visit www.santen.uk.

Roche

Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients. In ophthalmology their clinical programmes focus on some of the main causes of blindness and visual impairment globally, where the unmet need is high.

For further information on the company and its people, portfolio, and commitments, please visit www.roche.co.uk.

Secretariat

M+F Health

M+F Health provide Secretariat services to the Industry Vision Group. We are an independent, integrated communications and public affairs agency. Our work is meaningful – we aim to make a significant, positive impact on the health and wellbeing of the UK. We deliver on this every day through an unrivalled and deep understanding of the healthcare environment.